Document is current
Any future updates will be listed below
-
Authors
Hendrickx, Jhana O.
Van Keer, Severien
Donders, Gilbert
Weyers, Steven
Doyen, Jean
Beyers, Koen C. L.
Rios-Cortes, Alejandra
Meers, Nette
Téblick, Laura
Vankerckhoven, Vanessa V. J.
-
Funding
Funding for this research was provided by:
H2020 Eurostars (12396)
Research Foundation-Flanders (1240220N)
- License Information
-
More Information
Article History
Received: 16 May 2024
Accepted: 24 December 2024
First Online: 12 February 2025
Declarations
:
: Written informed consent for participation was obtained from all individual participants enrolled in the CASUS study. Ethical approval for the CASUS study was provided by the Medical Ethical Committee of the University Hospital Antwerp (20/21/271, Antwerp, Belgium) on the 4th of August 2020.
: Not applicable.
: J. O. Hendrickx, A. Rios-Cortes, N. Meers are employees of Novosanis. V.V.J. Vankerckhoven is co-founder and was board member and CEO of Novosanis until October 2022. K.C.L. Beyers is co-founder and was board member until December 2022 and CTO of Novosanis until July 2023. Novosanis was founded as a spin-off company of the University of Antwerp, Belgium and is a subsidiary of OraSure Technologies Inc. since Jan 2019. The University of Antwerp received payment for participation of S. Van Keer in an Advisory Board of Novosanis (Subsidiary of OraSure Technologies Inc. Wijnegem, Belgium).
